Your trusted source for investing success

Tag: Technology

Biotech Stocks in 2018

Find out how the market will look this year

Canntab to Commence Trading on CSE on 4/20

Canntab to Commence Trading on CSE on 4/20

Canntab Therapeutics Limited (CSE:PILL) (formerly Telferscot Resources Inc.) (“Canntab” or the “Company”) is pleased to announce that its common shares will commence trading on the Canadian Securities Exchange (the “CSE”) at the opening of the market on Friday, April 20, 2018 under the stock symbol “PILL”.

UTStarcom Announces SRv6 Router Product Line

UTStarcom (NASDAQ:UTSI), a global telecommunications infrastructure provider announced ‘POC-ready’ release of its newest break-through platform: the SkyFlux UAR series of routers which are based on Segment Routing over IPv6 data plane (SRv6) technology tightly integrated with the company’s SDN platform SOO network.

As quoted in the press release:
“UTStarcom takes pride in

CTG Reports 2018 First Quarter Results

CTG (NASDAQ:CTG), a leading provider of information technology (IT) solutions and services in North America and Western Europe announced its financial results for the first quarter ended March 30, 2018.

The company had a revenue of $82.8 million with their organic revenue in Europe increasing 10.1 per cent year to year

Syntel Reports First Quarter 2018 Financial Results

Syntel Inc (NASDAQ:SYNT), a leading global provider of integrated information technology and knowledge process services announced financial results for the first quarter ended March 31, 2018.

The company’s revenue for the first quarter increased 8.6 per cent to $245.3 million from $225.9 million as compared to previous year, and 2.3 per cent

Alternate Health Launches First Complete Ethereum Blockchain EMR / EHR

Alternate Health (CSE:AHG) has announced the transformation of the CanaPass patient management system to complete an ethereum-based blockchain electronic medical records and electronic health records system.

As quoted in the press release:
“Alternate Health’s blockchain EMR/EHR is the first of its kind and completes our comprehensive integration of blockchain technology into all

NeuroMetrix Reports Q1 2018 Financial Results

NeuroMetrix (Nasdaq:NURO) reported financial and business highlights for the quarter ended March 31, 2018.

As quoted in the press release:
The Company develops and markets novel therapies, based on neurostimulation and digital medicine, for chronic health conditions. The Company’s primary product is Quell®, which is an over-the-counter wearable neurostimulation device for treating

10+ Gold Stocks to Watch

Expert Insights.
Industry Stats.

Give me my free report!
Enter Your Log In Credentials
This setting should only be used on your home or work computer.


Privacy & Legal Policy

Privacy Policy

Investing News Network

Send this to a friend

I thought you might find this interesting:
Big News Roundup: Xanthic Biopharma Inc. Announces LOI with Licensed Producer, Green Mile Solutions LLC; Lexaria Achieves Significant Breakthrough in Alternative Nicotine Delivery Technology; Isodiol International Signs Agreement to Acquire 19.9% Equity into Leading Canadian Medical Cannabis Clinic